Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 6 di 6
Titolo Data di pubblicazione Autore(i) File
Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study. 2013 Rossi, Luigi; Tomao, Federica; Francini, Edoardo; LO RUSSO, Giuseppe; Papa, Anselmo; Zoratto, Federica; Raffaella, Marzano; Basso, Enrico; Giordani, Erika; Verrico, Monica; Fabio, Ricci; Giulia, Pasciuti; Tomao, Silverio
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer. A single-institution experience 2015 Petrioli, R; Francini, E; Roviello, F; Marrelli, D; Fiaschi, Ai; Laera, L; Rossi, G; Bianco, V; Brozzetti, Stefania; Roviello, G.
Rechallenge of docetaxel combined with epirubicin given on a weekly schedule in advanced castration-resistant prostate cancer patients previously exposed to docetaxel and abiraterone acetate. A single-institution experience 2015 Petrioli, R; Roviello, G; Fiaschi, Ai; Laera, L; Miano, St; De Rubertis, G; Barbanti, G; Bianco, V; Brozzetti, Stefania; Francini, E.
Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry 2019 Francini, Edoardo; Gray, Kathryn P; Shaw, Grace K; Evan, Carolyn P; Hamid, Anis A; Perry, Caitlin E; Kantoff, Philip W; Taplin, Mary-Ellen; Sweeney, Christopher J
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer 2019 Petrioli, Roberto; Marrelli, Daniele; Roviello, Franco; D'Ignazio, Alessia; Torre, Pamela; Chirra, Martina; Savelli, Vinno; Ambrosio, Maria Raffaella; Francini, Guido; Calomino, Natale; Farsi, Marco; Vernillo, Remo; Francini, Edoardo
Circulating free DNA (cfDNA) as biomarker of taxane resistance in metastatic castration-resistant prostate cancer (mCRPC) 2020 Francini, Edoardo
Mostrati risultati da 1 a 6 di 6
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile